Displaying drugs 101 - 125 of 162 in total
Iodine (131I) norcholesterol
Experimental
Diiodohydroxypropane
Experimental
Tetraethylammonium
Tetraethylammonium is an experimental drug with no approved indication or marketed formulation. The only marketed drug containing tetraethylammonium was a combination drug called Fosglutamina B6, but this drug has now been discontinued. As an experimental agent, tetraethylammonium is used in its salt forms such as tetraethylammonium chloride and tetraethylammonium bromide....
Experimental
Investigational
Matched Salts name: … Tetraethylammonium iodide …
5-Iodouracil
Experimental
8-iodo-guanine
Experimental
Iopydol
Experimental
Rose bengal lactone
Experimental
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
Ibacitabine
Experimental
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
Experimental
123I-iodometomidate
123I-iodometomidate is under investigation in clinical trial NCT00454103 (Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy).
Investigational
Diodone
Experimental
Matched Iupac: … 2-(3,5-diiodo-4-oxo-1,4-dihydropyridin-1-yl)acetic acid; 2-[(2-hydroxyethyl)amino]ethan-1-ol …
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
Experimental
Matched Iupac: … 3S,5R)-3-hydroxy-5-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic acid …
Iodo-Willardiine
Experimental
Matched Iupac: … (2S)-2-amino-3-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)propanoic acid …
Zelavespib
Zelavespib (PU-H71) has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).
Investigational
Fiacitabine
Fiacitabine has been used in trials studying the treatment of HIV Infections and Cytomegalovirus Infections.
Investigational
Ropidoxuridine
Ropidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR, which demonstrated a survival advantage in Phase II studies in anaplastic astrocytoma, a type of brain tumor.
Investigational
9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE
Experimental
MIP-1095 I-123
123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents).
Investigational
Matched Iupac: … 2S)-2-({[(1S)-1-carboxy-5-({[4-(¹²³I)iodophenyl]carbamoyl}amino)pentyl]carbamoyl}amino)pentanedioic acid …
Displaying drugs 101 - 125 of 162 in total